Tag: Patient Safety

Racial, ethnic disparities in cancer care during COVID-19

Editor's Note This national survey study led by researchers from Stanford University finds that the COVID-19 pandemic was linked to disparities in the receipt of timely cancer care in Black and Latinx adults. Of 1,240 adult cancer patients surveyed, Black and Latinx respondents had greater odds of : involuntary treatment…

Read More

By: Judy Mathias
July 18, 2022
Share

FDA: Class I recall of American Contract Systems' COVID Test Kit Nonsterile, Clean Catch Urine Kit

Editor's Note The Food and Drug Administration (FDA) on July 14 identified the recall of American Contract Systems’ COVID Test Kit Nonsterile and Clean Catch Urine Kit as Class I, the most serious. The recall was initiated because the Kits were assembled in an uncontrolled facility by people without proper…

Read More

By: Judy Mathias
July 18, 2022
Share

Long-term immune response to COVID-19 in children, adults

Editor's Note This Italian study describes the long-term features of the immune response to COVID-19 for different ages after mild infection. In this cohort of 252 family clusters with COVID-19, the immune response persisted until 12 months after infection in all age groups, with significantly higher antibody peaks for younger…

Read More

By: Judy Mathias
July 13, 2022
Share

Researchers develop model to explain Long COVID

Editor's Note In this study, researchers in New Zealand identify how post-viral fatigue syndromes, including Long COVID, become life-changing diseases and why patients have frequent relapses. Viral infections commonly result in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, which causes brain-centered symptoms of neuroinflammation, brain fog, lack of refreshing sleep, and poor response…

Read More

By: Judy Mathias
July 13, 2022
Share

UH Cleveland Medical Center awarded AHA Quest for Quality Prize

Editor's Note The American Hospital Association (AHA) will present this year’s Quest for Quality Prize to University Hospitals Cleveland Medical Center (UH) on July 18 at the AHA Leadership Summit in San Diego. UH is receiving the award because of its data-driven quality and safety improvements and innovative strategies to…

Read More

By: Judy Mathias
July 13, 2022
Share

FDA: Class I recall of Getinge Flow-c, Flow-e Anesthesia Systems

Editor's Note The Food and Drug Administration (FDA) on July 6 identified the recall by Getinge USA Sales Inc of its Flow-c and Flow-e Anesthesia Systems as Class I, the most serious. The recall was initiated after reports of cracked or broken on/off switchs on the systems’ suction units. If…

Read More

By: Judy Mathias
July 12, 2022
Share

FDA recommends updating boosters to target Omicron

Editor's Note The Food and Drug Administration’s (FDA’s) Vaccines and Related Biological Products Advisory Committee on June 28 recommended updating the composition of COVID-19 booster vaccines to target the Omicron variant. The Committee noted that booster doses consisting of an Omicron monovalent or bivalent vaccine could improve neutralizing antibody responses…

Read More

By: Judy Mathias
June 30, 2022
Share

The Joint Commission issues new Quick Safety on managing packaged sterile supplies, devices

Editor's Note The Joint Commission, on June 28, announced a new Quick Safety advisory on “Managing packaged sterile supplies and devices.” The advisory provides guidance to keep patients safe from infection and harm from expired or compromised supplies and devices and urges healthcare workers (HCWs) to pay close attention to…

Read More

By: Judy Mathias
June 29, 2022
Share

FDA: Class I recall of GE Healthcare’s CARESCAPE R860 Ventilator

Editor's Note The Food and Drug Administration (FDA) on June 28 identified the recall by GE Healthcare of its CARESCAPE R860 Ventilator as Class I, the most serious. The recall was initiated because the ventilator backup batteries, including replacement backup batteries, may run out before they are expected to do…

Read More

By: Judy Mathias
June 29, 2022
Share

FDA: Class I recall of Baxter’s Volara system with in-line ventilator adaptor

Editor's Note The Food and Drug Administration (FDA) on June 23 identified the recall by Baxter Healthcare Corporation of its Volara system with in-line ventilator adaptor as Class I, the most serious. The Volara system is used to clear mucus out of airways, expand lungs, and treat or prevent pulmonary…

Read More

By: Judy Mathias
June 28, 2022
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat